LexaGene Holdings Inc. Aktie Toronto S.E.
Aktien
A2ATW9
CA52886L1031
LXG.H
Biotechnologie
Manager | Titel | Alter | Seit |
---|---|---|---|
Jack Regan
CEO | Chief Executive Officer | - | 26.04.07 |
Jeffrey Mitchell
DFI | Director of Finance/CFO | - | 01.03.18 |
Steven Armstrong
COO | Chief Operating Officer | - | 24.03.20 |
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Joseph P. Caruso
BRD | Director/Board Member | 65 | 18.06.18 |
Jack Regan
CEO | Chief Executive Officer | - | 26.04.07 |
Tom Slezak
BRD | Director/Board Member | - | 12.10.16 |
% 1. Jan. | Kap. | |
---|---|---|
-16,10 % | 11,13 Mrd. | |
+67,65 % | 3,6 Mrd. | |
-30,20 % | 2,26 Mrd. | |
-14,31 % | 2,16 Mrd. | |
-26,03 % | 1,54 Mrd. | |
+36,95 % | 1,17 Mrd. | |
-2,40 % | 744 Mio. | |
-38,57 % | 432 Mio. | |
+13,72 % | 357 Mio. |